AQUINOX PHARMACEUTICALS, INC (32) | License Agreements (2)
- Amendment No. 1 to Exclusive Start-Up License Agreemen (Filed With SEC on March 25, 2021)
- Exclusive Start-Up License Agreement, dated July 8, 2019, by and between the University of Washington and Neoleukin Therapeutics, Inc (Filed With SEC on August 12, 2019)
